Meta-Analysis of Paediatric Patients with Central Precocious Puberty Treated with Intramuscular Triptorelin 11.25 mg 3-Month Prolonged-Release Formulation.

Background/Aims: A meta-analysis was undertaken to assess the effect of triptorelin 11.25 mg 3-month prolongedrelease formulation in central precocious puberty […]

May 27, 2025
HomaPharmed
0 comments

Background/Aims: A meta-analysis was undertaken to assess the effect of triptorelin 11.25 mg 3-month prolongedrelease formulation in central precocious puberty (CPP).

دانلود فایل PDF

Home

Contact

No.26, Nader Alley, Parvin St, West Fatemi St. Tehran, Iran

+98 21 62769000

info@homapharmed.com

Subscribe Us
Copyright @Dotline 2023